Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Cancer and Metastasis Reviews · 2024-09 · 43 (3) · 1095-1116
DOI: 10.1007/s10555-024-10186-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, online erschienen am 11.04.2024. Verfasst von Tianchen Guo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, Ch…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Neoplasms, Tumor Microenvironment, Neoplasm Metastasis. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, 4+X Clinical Research Project of Women's Hospital, School of Medicine, Zhejiang University.
Abstract (Originalsprache)
Tumor microenvironment (TME) has been demonstrated to play a significant role in tumor initiation, progression, and metastasis. Cancer-associated fibroblasts (CAFs) are the major component of TME and exhibit heterogeneous properties in their communication with tumor cells. This heterogeneity of CAFs can be attributed to various origins, including quiescent fibroblasts, mesenchymal stem cells (MSCs), adipocytes, pericytes, endothelial cells, and mesothelial cells. Moreover, single-cell RNA sequencing has identified diverse phenotypes of CAFs, with myofibroblastic CAFs (myCAFs) and inflammatory CAFs (iCAFs) being the most acknowledged, alongside newly discovered subtypes like antigen-presenting CAFs (apCAFs). Due to these heterogeneities, CAFs exert multiple functions in tumorigenesis, cancer stemness, angiogenesis, immunosuppression, metabolism, and metastasis. As a result, targeted therapies aimed at the TME, particularly focusing on CAFs, are rapidly developing, fueling the promising future of advanced tumor-targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China.
- Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, Zhejiang, China. xjfzu@zju.edu.cn.
ORCID-Profile: Junfen Xu
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- 4+X Clinical Research Project of Women's Hospital, School of Medicine, Zhejiang University
- Key Program of Zhejiang Province Natural Science Foundation of China
Zitieren
APA
Guo, T., & Xu, J. (2024). Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer and Metastasis Reviews, 43(3), 1095-1116. https://doi.org/10.1007/s10555-024-10186-7
Vancouver
Guo T, Xu J. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer and Metastasis Reviews. 2024;43(3):1095-1116. doi:10.1007/s10555-024-10186-7
BibTeX
@article{Guo2024,
author = {Guo, Tianchen and Xu, Junfen},
title = {Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy},
journal = {Cancer and Metastasis Reviews},
year = {2024},
volume = {43},
number = {3},
pages = {1095--1116},
doi = {10.1007/s10555-024-10186-7}
}
EUVIMED